About lab
Zhu2015 - combined gemcitabine and birinapantin pancreatic cancer cells - mechanistic PD model Mechanistic mathematical model toillustrate the effectiveness of combination chemotherapy involvinggemcit. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagezhu2015-combined-gemcitabine-and-birinapant-in-pancreatic-cancer
Created2026-05-16
Updated2026-05-16
biomodels_ebichemotherapycurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "gemcitabine_concentration",
"label": "Gemcitabine Concentration",
"units": "native SBML value",
"default": 20,
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.gemcitabine_concentration",
"description": "Gemcitabine Concentration. Overrides bundled SBML parameter `C_g`."
},
{
"name": "birinapant_concentration",
"label": "Birinapant Concentration",
"units": "native SBML value",
"default": 500,
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.birinapant_concentration",
"description": "Birinapant Concentration. Overrides bundled SBML parameter `C_b`."
},
{
"name": "initial_g1_cells",
"label": "G1 Cells",
"units": "native SBML value",
"default": 113516,
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.initial_g1_cells",
"description": "Initial G1 Cells. Sets the initial value of bundled SBML symbol `G1`."
},
{
"name": "initial_g2_cells",
"label": "G2 Cells",
"units": "native SBML value",
"default": 81656,
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.initial_g2_cells",
"description": "Initial G2 Cells. Sets the initial value of bundled SBML symbol `G2`."
}
],
"outputs": [
{
"name": "g1_cells",
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.g1_cells",
"description": "G1 Cells observable. Maps to SBML symbol `G1`."
},
{
"name": "s_phase_cells",
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.s_phase_cells",
"description": "S-Phase Cells observable. Maps to SBML symbol `S`."
},
{
"name": "g2_cells",
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.g2_cells",
"description": "G2 Cells observable. Maps to SBML symbol `G2`."
},
{
"name": "apoptotic_response",
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.apoptotic_response",
"description": "Apoptotic Response observable. Maps to SBML symbol `R_apo`."
},
{
"name": "other_response",
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.other_response",
"description": "Other Response observable. Maps to SBML symbol `R_other`."
},
{
"name": "state",
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"chemotherapy",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth"
],
"title": "Zhu2015 - Combined gemcitabine and birinapant in pancreatic cancer cells - mechanistic PD model Lab",
"models": [
{
"path": "owned/models/oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model",
"alias": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model",
"provenance": {
"owned_path": "owned/models/oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model_state"
],
"from": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.state"
},
{
"to": [
"visualisation.oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model_summary"
],
"from": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model_species_labels"
],
"from": "oncology_sbml_zhu2015_combined_gemcitabine_and_birinapant_in_p_biomd0000000669_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "Zhu2015 - combined gemcitabine and birinapantin pancreatic cancer cells - mechanistic PD model Mechanistic mathematical model toillustrate the effectiveness of combination chemotherapy involvinggemcit. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.